NCT06811623

Brief Summary

Laparoscopic sleeve gastrectomy (LSG) is a restrictive bariatric operation, has become one of the most commonly performed bariatric surgeries. Postoperative gastrointestinal complications are agonizing in patients underwent this procedure. Most of these complications can be prevented by omentopexy in association with sleeve gastrectomy. The Primary aim of this study to assess the effectiveness of omentopexy during laparoscopic sleeve gastrectomy in reducing post-operative complication.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
9.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

January 26, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 6, 2025

Completed
Last Updated

February 6, 2025

Status Verified

January 1, 2025

Enrollment Period

9.8 years

First QC Date

January 26, 2025

Last Update Submit

January 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • post-operative complications

    post operative nausea, vomiting and leakage

    6 months

Secondary Outcomes (1)

  • operative time and hospital stay

    6 months

Study Arms (2)

Group with Omentopexy

ACTIVE COMPARATOR

Laparoscopic Sleeve Gastrectomy with omentopexy

Procedure: Laparoscopic Sleeve Gastrectomy with omentopexy

Group without Omentopexy

ACTIVE COMPARATOR

Laparoscopic Sleeve Gastrectomy without omentopexy

Procedure: Laparoscopic Sleeve Gastrectomy without omentopexy

Interventions

Laparoscopic Sleeve Gastrectomy with omental fixation to the gastric tube

Group with Omentopexy

Laparoscopic Sleeve Gastrectomy without omental fixation to the gastric tube

Group without Omentopexy

Eligibility Criteria

Age6 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • body mass index (BMI) of 40 kg/m2 or
  • BMI of 35 kg/m2 due to at least 1 comorbid condition

You may not qualify if:

  • secondary obesity
  • more than 18 years
  • previous operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Obesity, MorbidPediatric Obesity

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mohammad Daboos

    Al-Azhar University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: group 1: included 24 patients managed with Laparoscopic Sleeve Gastrectomy with omentopexy and group 2: included 24 patients managed with Laparoscopic Sleeve Gastrectomy without omentopexy.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor at Pediatric Surgery Department, Al-Azhar University.

Study Record Dates

First Submitted

January 26, 2025

First Posted

February 6, 2025

Study Start

January 1, 2015

Primary Completion

October 1, 2024

Study Completion

January 1, 2025

Last Updated

February 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share